ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 73

Circular RNAs Expression Profile in Chinese Rheumatoid Arthritis Patients at Different Disease Activity

Huan Liu, Qibing Xie and Geng Yin, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Disease Activity and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Circular RNAs Expression Profile in Chinese Rheumatoid Arthritis Patients at Different Disease Activity

Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune-mediated chronic inflammatory joint disease, that is still no clear pathogenesis for patients to be cured in a timely manner. Circular RNAs (circRNAs) have been recently identified as noncoding RNAs in most common model organisms and show potential as gene regulators. Here, we profiled the circRNAs expression of RA at different disease activity to improve our understanding of RA pathogenesis.

Methods:

Expression profiling was performed by high throughput sequencing using whole blood RNA samples obtained from 12 RA patients. In each group there were 3 patients at low, moderate, high disease activity, respectively, as well as 3 heathy controls. Quantitative real time reverse-transcription polymerase chain reaction (qRT-PCR) was used to identified the differential circRNAs. Spearman correlation test assessed the correlation of circRNAs and clinical variables.

Results:

Compared to health controls, a total of 155 circRNAs and 161 circRNAs were significantly upregulated and downregulated, respectively, in RA patients. qRT‑PCR detection showed that the expres­sion levels of downregulated circRNA_29264 (hsa_circ_0007889), upregulated circRNA_19131 (hsa_circ_0003123) decreased as the disease activity increased, upregulated circRNA_02235 was higher in remission than other disease activities. The correlation test showed the negative correlation among three circRNAs and C-reactive protein (CRP), health assessment questionnaire (HAQ), VAS pain score, disease activity score in 28 joints(DAS28), clinical disease activity index(CDAI) and simplified disease activity index(SDAI), respectively.

Conclusion:

This work illustrates that circRNAs dysregulation may play a role in RA pathogenesis, and three key circRNAs show promise as candidate biomarkers for development of RA.


Disclosure: H. Liu, None; Q. Xie, None; G. Yin, None.

To cite this abstract in AMA style:

Liu H, Xie Q, Yin G. Circular RNAs Expression Profile in Chinese Rheumatoid Arthritis Patients at Different Disease Activity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/circular-rnas-expression-profile-in-chinese-rheumatoid-arthritis-patients-at-different-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/circular-rnas-expression-profile-in-chinese-rheumatoid-arthritis-patients-at-different-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology